These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9252194

  • 21. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
    Martelli L, Di Mario F, Botti P, Ragazzi E, Martelli M, Kelland L.
    Biochem Pharmacol; 2007 Jun 30; 74(1):20-7. PubMed ID: 17466278
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Detection of platinum-DNA adducts by 32P-postlabelling.
    Blommaert FA, Saris CP.
    Nucleic Acids Res; 1995 Apr 25; 23(8):1300-6. PubMed ID: 7753620
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate.
    Treskes M, Nijtmans LG, Fichtinger-Schepman AM, van der Vijgh WJ.
    Biochem Pharmacol; 1992 Mar 03; 43(5):1013-9. PubMed ID: 1313234
    [Abstract] [Full Text] [Related]

  • 26. The formation and persistence of carboplatin-DNA adducts in rats.
    Blommaert FA, Michael C, van Dijk-Knijnenburg HC, Schornagel JH, den Engelse L, Fichtinger-Schepman AM.
    Cancer Chemother Pharmacol; 1996 Mar 03; 38(3):273-80. PubMed ID: 8646803
    [Abstract] [Full Text] [Related]

  • 27. In vitro studies on the mechanisms of oxaliplatin resistance.
    Hector S, Bolanowska-Higdon W, Zdanowicz J, Hitt S, Pendyala L.
    Cancer Chemother Pharmacol; 2001 Nov 03; 48(5):398-406. PubMed ID: 11761458
    [Abstract] [Full Text] [Related]

  • 28. Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation.
    Fichtinger-Schepman AM, van der Velde-Visser SD, van Dijk-Knijnenburg HC, van Oosterom AT, Baan RA, Berends F.
    Cancer Res; 1990 Dec 15; 50(24):7887-94. PubMed ID: 2253228
    [Abstract] [Full Text] [Related]

  • 29. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
    Dempke WC, Shellard SA, Hosking LK, Fichtinger-Schepman AM, Hill BT.
    Carcinogenesis; 1992 Jul 15; 13(7):1209-15. PubMed ID: 1638688
    [Abstract] [Full Text] [Related]

  • 30. Cisplatin- and carboplatin-DNA adducts: is PT-AG the cytotoxic lesion?
    Fichtinger-Schepman AM, van Dijk-Knijnenburg HC, van der Velde-Visser SD, Berends F, Baan RA.
    Carcinogenesis; 1995 Oct 15; 16(10):2447-53. PubMed ID: 7586150
    [Abstract] [Full Text] [Related]

  • 31. Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment.
    Nel I, Gauler TC, Eberhardt WE, Nickel AC, Schuler M, Thomale J, Hoffmann AC.
    Br J Cancer; 2013 Sep 03; 109(5):1223-9. PubMed ID: 23942068
    [Abstract] [Full Text] [Related]

  • 32. Optimized sample preparation strategy for the analysis of low molecular mass adducts of a fluorescent cisplatin analogue in cancer cell lines by CE-dual-LIF.
    Zabel R, Kullmann M, Kalayda GV, Jaehde U, Weber G.
    Electrophoresis; 2015 Feb 03; 36(4):509-17. PubMed ID: 25483804
    [Abstract] [Full Text] [Related]

  • 33. Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells.
    Johnson SW, Swiggard PA, Handel LM, Brennan JM, Godwin AK, Ozols RF, Hamilton TC.
    Cancer Res; 1994 Nov 15; 54(22):5911-6. PubMed ID: 7954422
    [Abstract] [Full Text] [Related]

  • 34. Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy.
    Meijer C, de Vries EG, Marmiroli P, Tredici G, Frattola L, Cavaletti G.
    Neurotoxicology; 1999 Dec 15; 20(6):883-7. PubMed ID: 10693969
    [Abstract] [Full Text] [Related]

  • 35. Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.
    Tilby MJ, Johnson C, Knox RJ, Cordell J, Roberts JJ, Dean CJ.
    Cancer Res; 1991 Jan 01; 51(1):123-9. PubMed ID: 1703029
    [Abstract] [Full Text] [Related]

  • 36. Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy.
    Veal GJ, Dias C, Price L, Parry A, Errington J, Hale J, Pearson AD, Boddy AV, Newell DR, Tilby MJ.
    Clin Cancer Res; 2001 Aug 01; 7(8):2205-12. PubMed ID: 11489793
    [Abstract] [Full Text] [Related]

  • 37. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
    Chijiwa S, Masutani C, Hanaoka F, Iwai S, Kuraoka I.
    Carcinogenesis; 2010 Mar 01; 31(3):388-93. PubMed ID: 20015866
    [Abstract] [Full Text] [Related]

  • 38. A feasibility study of the use of saliva as an alternative to leukocytes as a source of DNA for the study of Pt-DNA adducts in cancer patients receiving platinum-based chemotherapy.
    Taylor SE, Wood JP, Thomas AL, Jones GD, Reid HJ, Sharp BL.
    Anal Bioanal Chem; 2014 Dec 01; 406(30):8033-6. PubMed ID: 25374124
    [Abstract] [Full Text] [Related]

  • 39. Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin.
    Liedert B, Materna V, Schadendorf D, Thomale J, Lage H.
    J Invest Dermatol; 2003 Jul 01; 121(1):172-6. PubMed ID: 12839578
    [Abstract] [Full Text] [Related]

  • 40. Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.
    Liedert B, Pluim D, Schellens J, Thomale J.
    Nucleic Acids Res; 2006 Mar 29; 34(6):e47. PubMed ID: 16571898
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.